SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Aspen Neuroscience shares fall on Nasdaq debut after IPO

The drug developer completed a U.S. IPO before its shares fell on their first day of Nasdaq trading.

QQQ

Related stories